Bought (120 mo)
$269.88K
out of their own pocket, the only kind of buying there is
There is no salary here to measure against. Transcode Therapeutics, Inc.'s chief executive is paid a token, so dividing a holding by it says nothing.
Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.
No percentages here. This company's share count has moved by a factor of 28.0 over the window, from 833,683 to 23,341,336 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.
Nothing of that kind in this period.